Frontlight ResearchEarly access
Ovarian cancer trials in United States
348 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
- Where
- Baltimore, Basking Ridge, Boston, Commack, Harrison, Houston, Middletown, Montvale, New York, Uniondale
- Age
- 45 years and over
- People
- 266
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06312124 - No phaseTaking peopleUtero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy
- Where
- Tampa
- Age
- 18 months to 40 months
- People
- 26
- Run by
- University of South Florida
See details and how to joinNCT07419490 - Phase 1Taking peopleStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Where
- Austin, Chicago, Duarte, Durham, Fairfax, Fort Wayne, Grand Rapids, Houston, Huntersville, Indianapolis, Irvine, Irving, Los Angeles, Louisville, Minneapolis, Omaha, San Antonio, West Valley City
- Age
- 18 years and over
- People
- 694 worldwide
- Run by
- AbbVie
See details and how to joinNCT05005403 - Phase 2Taking peopleLeuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
- Where
- Ann Arbor
- Age
- 18 years and over
- People
- 75
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT07158021 - Phase 2Taking peopleZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 33
- Run by
- Alexander B Olawaiye, MD
See details and how to joinNCT05071937 - Phase 2Taking peopleVismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 48
- Run by
- Ronald Buckanovich
See details and how to joinNCT05538091 - No phaseTaking peopleFamilial Investigations of Childhood Cancer Predisposition
- Where
- Memphis
- People
- 1,500
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT03050268 - Phase 2Taking peopleONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
- Where
- Detroit, Flint
- Age
- 18 years and over
- People
- 62
- Run by
- Ira Winer
See details and how to joinNCT04055649 - No phaseTaking peoplePilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
- Where
- Boston
- Age
- 18 years and over
- People
- 112
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06543537 - Phase 2/3Not yet taking people in United StatesStudy to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
- Where
- Grand Rapids
- Age
- 18 years and over
- People
- 175 worldwide
- Run by
- GE Healthcare
See details and how to joinNCT07219238 · EU 2024-519384-18-00 - No phaseTaking peopleAdapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
- Where
- Seattle
- Age
- 18 years and over
- People
- 25
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07282158 - Phase 1Taking peopleStudy of STP938 (Dencatistat) in Advanced Solid Tumours
- Where
- Dallas, San Antonio, St. Petersburg
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- Step Pharma, SAS
See details and how to joinNCT06297525 · EU 2024-512375-12-00 - Phase 1Taking peopleIntraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
- Where
- Boston
- Age
- 18 years to 85 years
- People
- 18
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06321484 - Phase 1Taking peopleDose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
- Where
- Fort Worth, Los Angeles, West Valley City
- Age
- 18 years and over
- People
- 40
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT07517198 - No phaseTaking peopleThe EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
- Where
- Aurora, Boulder
- Age
- 18 years and over
- People
- 250
- Run by
- University of Colorado, Boulder
See details and how to joinNCT07636200 - Phase 1Taking peopleStudy of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
- Where
- Boston, Columbus, New York, Pittsburgh, Santa Monica, Tampa
- Age
- 18 years and over
- People
- 52 worldwide
- Run by
- Senhwa Biosciences, Inc.
See details and how to joinNCT04890613 - Phase 1/2Taking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- Where
- Atlanta, Augusta, Baltimore, Camden, Charleston, Charlottesville, Chattanooga, Chicago, Cincinnati, Coral Gables, Detroit, Hilliard, Houston, Little Rock, Louisville, Nashville, New York, Palo Alto, Portland, Skokie, Tampa, Tucson
- Age
- 18 years and over
- People
- 182 worldwide
- Run by
- Eisai Inc.
See details and how to joinNCT04300556 · EU 2023-506868-14-00 - Phase 2Taking peopleA Study of Lorigerlimab in Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Houston, Los Angeles, Madison, New Orleans, Pittsburgh, San Antonio
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06730347 - Phase 2Taking peopleA Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
- Where
- Detroit, Edgewood, Houston, Lexington, Pittsburgh, Sarasota, Worcester
- Age
- 18 years and over
- People
- 110 worldwide
- Run by
- AbbVie
See details and how to joinNCT06682988 · EU 2024-517184-23-00 - No phaseTaking peopleEvaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
- Where
- Atlanta
- Age
- 25 years and over
- People
- 3,209
- Run by
- Emory University
See details and how to joinNCT06760507 - Phase 1/2Taking peopleJAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
- Where
- Canton, Cleveland, Denver, Houston, Lake Mary, Nashville, St Louis
- Age
- 18 years and over
- People
- 144 worldwide
- Run by
- Jacobio Pharmaceuticals Co., Ltd.
See details and how to joinNCT06386146 - Phase 2Taking peopleA Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
- Where
- Tampa
- Age
- 18 years and over
- People
- 114 worldwide
- Run by
- Oncoinvent Solutions AS
See details and how to joinNCT06504147 - Phase 1Taking peopleAutologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 27
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT06305299 - No phaseNot yet taking people in United StatesA Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American Families
- Where
- Ann Arbor
- Age
- 18 years and over
- People
- 150
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT07542405 - No phaseTaking peopleGenetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
- Where
- Stanford
- Age
- 18 years and over
- People
- 3,300
- Run by
- Stanford University
See details and how to joinNCT01034033